Preliminary results of active specific immunization with modified tumor cell vaccine in glioblastoma multiforme.
作者： Thomas Schneider , Roswitha Gerhards , Elmar Kirches , Raimund Firsching
关键词:
摘要: Object Treatment for glioblastoma multiforme has failed to show any progress decades. While specific immunization with tumor cells modified Newcastle-Disease-Virus (NDV) been reported successful in some extracerebral tumors, its effect on is unknown. We report 11 patients, whom this approach was analyzed.
springer.com
sci-hub.se 参考文章(47)
Roger I. von Hanwehr, Florence M. Hofman, Clive R. Taylor, Michael L. J. Apuzzo, Mononuclear lymphoid populations infiltrating the microenvironment of primary CNS tumors. Characterization of cell subsets with monoclonal antibodies. Journal of Neurosurgery. ,vol. 60, pp. 1138- 1147 ,(1984) , 10.3171/JNS.1984.60.6.1138
Paul von Hoegen, Rainer Zawatzky, Volker Schirrmacher, Modification of tumor cells by a low dose of Newcastle disease virus. III. Potentiation of tumor-specific cytolytic T cell activity via induction of interferon-alpha/beta. Cellular Immunology. ,vol. 126, pp. 80- 90 ,(1990) , 10.1016/0008-8749(90)90302-8
H C Hoover, J S Brandhorst, L C Peters, M G Surdyke, Y Takeshita, J Madariaga, L R Muenz, M G Hanna, Adjuvant active specific immunotherapy for human colorectal cancer: 6.5-year median follow-up of a phase III prospectively randomized trial. Journal of Clinical Oncology. ,vol. 11, pp. 390- 399 ,(1993) , 10.1200/JCO.1993.11.3.390
M. Stephen Mahaley, G. Yancey Gillespie, Ritchie P. Gillespie, Pamela J. Watkins, Darell D. Bigner, Carol J. Wikstrand, J. Marilyn MacQueen, Fred Sanfilippo, Immunobiology of primary intracranial tumors: Part 8: Serological responses to active immunization of patients with anaplastic gliomas Journal of Neurosurgery. ,vol. 59, pp. 208- 216 ,(1983) , 10.3171/JNS.1983.59.2.0208
Marius Maxwell, Theofanis Galanopoulos, Janine Neville-Golden, Harry N. Antoniades, Effect of the expression of transforming growth factor-β2 in primary human glioblastomas on immunosuppression and loss of immune surveillance Journal of Neurosurgery. ,vol. 76, pp. 799- 804 ,(1992) , 10.3171/JNS.1992.76.5.0799
Paul L. Kornblith, Michael Walker, Chemotherapy for malignant gliomas. Journal of Neurosurgery. ,vol. 68, pp. 1- 17 ,(1988) , 10.3171/JNS.1988.68.1.0001
Marie Marchand, Francis Brasseur, Pierre van der Bruggen, Pierre Coulie, Thierry Boon, None, Perspectives for immunization of HLA-A1 patients carrying a malignant-melanoma expressing gene MAGE-1 Dermatology. ,vol. 186, pp. 278- 280 ,(1993) , 10.1159/000247375
Herbert C. Hoover, Mildred G. Surdyke, Ruth B. Dangel, Leona C. Peters, Michael G. Hanna, Prospectively randomized trial of adjuvant active-specific immunotherapy for human colorectal cancer. Cancer. ,vol. 55, pp. 1236- 1243 ,(1985) , 10.1002/1097-0142(19850315)55:6<1236::AID-CNCR2820550616>3.0.CO;2-#
M. K. Gately, M. Glaser, R. M. McCarron, S. J. Dick, M. D. Dick, R. W. Mettetal, P. L. Kornblith, Mechanisms by which human gliomas may escape cellular immune attack Acta Neurochirurgica. ,vol. 64, pp. 175- 197 ,(1982) , 10.1007/BF01406052
V. Schirrmacher, Active Specific Immunotherapy – A New Modality of Cancer Treatment Involving the Patient’s Own Immune System Onkologie. ,vol. 16, pp. 290- 296 ,(1993) , 10.1159/000218281